intranasal glutathione in parkinson& 39 Revamping Parkinson's disease therapy using
Revamping Parkinson's disease therapy using PLGA based drug delivery systems npj Parkinson's Disease Parkinson's Disease: The Epidemiology, Risk Factors, Molecular Pathogenesis, Prevention, and Therapy PMC Innovative approach in Parkinson's targeting via berberine loaded mucoadhesive surface modified liposomes: a multi faceted study BMC Pharmacology and Toxicology Springer Nature Link Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease ScienceDirect
Pay in 4 interest-free payments of $7.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10



